Adherence to Rheumatoid Arthritis (RA) DMARDs, Research in Progress from the Forward Databank

Dr. Kaleb Michaud's presentation for the UNC CCCR speaker series on March 23, 2022. While providing an overview of the Forward Databank, a 24-year and ongoing observational study driven by patient participation, Dr. Michaud focuses his talk on his recent studies of adherence to common DMARDs for treating RA including MTX, tofacitinib, and injectable TNFi using electronically-capped bottles. He also covers recent findings on resistance
to changing DMARDs by patients with RA.